Skip to Main Content

Paper Details

Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission.
Am J Gastroenterol
7
2023
Author NameAffiliation
Phillip GuCenter for Inflammatory Bowel Diseases, Cedars Sinai Medical Center
Gil Y MelmedCenter for Inflammatory Bowel Diseases, Cedars Sinai Medical Center
  • 1 - 2

Datasets

Release 1.2